The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: A 5-year randomised controlled trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 5, 2007, Pages 563-568

  Halmesmaki K ^a   Hurskainen, R ^a   Teperi, J ^b   Grenman, S ^c   Kivela A ^d   Kujansuu, E ^e   Tuppurainen, M ^f   Yliskoski, M ^g   Vuorma, S ^b   Paavonen, J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

^g JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

Author keywords

Hysterectomy; LNG IUS; Menorrhagia; Sexual functioning; Sexuality

Indexed keywords

ESTROGEN; LEVONORGESTREL;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HEALTH SURVEY; HOT FLUSH; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENORRHAGIA; NIGHT SWEAT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL SATISFACTION; SMOKING; TREATMENT OUTCOME; VAGINAL DRYNESS;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; HYSTERECTOMY; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENORRHAGIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SATISFACTION; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 34247149423     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01306.x     Document Type: Article

References (39)

1. Shapley M, Jordan K, Croft PR. An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract 2004;54:359-63.
2. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001;357:273-7.
3. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004;291:1456-63.
4. Kilkku P, Gronroos M, Hirvonen T, Rauramo L. Supravaginal uterine amputation vs. hysterectomy. Effects on libido and orgasm. Acta Obstet Gynecol Scand 1983;62:147-52.
5. Maas CP, Kenter GG, Trimbos B. Outcomes after total versus subtotal abdominal hysterectomy. N Engl J Med 2003;348:856-7.
6. McPherson K, Herbert A, Judge A, Clarke A, Bridgman S, Maresh M, et al. Psychosexual health 5 years after hysterectomy: population-based comparison with endometrial ablation for dysfunctional uterine bleeding. Health Expect 2005;8:234-43.
7. Siddle N, Sarrel P, Whitehead M. The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987;47:94-100.
8. Oldenhave A, Jaszmann LJ, Everaerd WT, Haspels AA. Hysterectomized women with ovarian conservation report more severe climacteric complaints than do normal climacteric women of similar age. Am J Obstet Gynecol 1993;168:765-71.
9. Hartmann BW, Kirchengast S, Albrecht A, Metka M, Huber JC. Hysterectomy increases the symptomatology of postmenopausal syndrome. Gynecol Endocrinol 1995;9:247-52.
10. Derksen JG, Brolmann HA, Wiegerinck MA, Vader HL, Heintz AP. The effect of hysterectomy and endometrial ablation on follicle stimulating hormone (FSH) levels up to 1 year after surgery. Maturitas 1998;29:133-8.
11. Cooper GS, Thorp JM Jr. FSH levels in relation to hysterectomy and to unilateral oophorectomy. Obstet Gynecol 1999;94:969-72.
12. Stadberg E, Mattsson LA, Milsom I. Factors associated with climacteric symptoms and the use of hormone replacement therapy. Acta Obstet Gynecol Scand 2000;79:286-92.
13. Nahas E, Pontes A, Traiman P, NahasNeto J, Dalben I, De Luca L. Inhibin B and ovarian function after total abdominal hysterectomy in women of reproductive age. Gynecol Endocrinol 2003;17:125-31.
14. Halmesmaki K, Hurskainen R, Tiitinen A, Teperi J, Grenman S, Kivela A, et al. A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia-effect on FSH levels and menopausal symptoms. Hum Reprod 2004;19:378-82.
15. Farquhar CM, Sadler L, Harvey SA, Stewart AW. The association of hysterectomy and menopause: a prospective cohort study. BJOG 2005;112:956-62.
16. Thakar R, Ayers S, Clarkson P, Stanton S, Manyonda I. Outcomes after total versus subtotal abdominal hysterectomy. N Engl J Med 2002;347:1318-25.
17. Ellstrom MA, Astrom M, Moller A, Olsson JH, Hahlin M. A randomized trial comparing changes in psychological well-being and sexuality after laparoscopic and abdominal hysterectomy. Acta Obstet Gynecol Scand 2003;82:871-5.
18. Zobbe V, Gimbel H, Andersen BM, Filtenborg T, Jakobsen K, Sorensen HC, et al. Sexuality after total vs. subtotal hysterectomy. Acta Obstet Gynecol Scand 2004;83:191-6.
19. Kuppermann M, Summitt RL Jr, Varner RE, McNeeley SG, Goodman-Gruen D, Learman LA, et al. Sexual functioning after total compared with supracervical hysterectomy: a randomized trial. Obstet Gynecol 2005;105:1309-18.
20. Alexander DA, Naji AA, Pinion SB, Mollison J, Kitchener HC, Parkin DE, et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ 1996;312:280-4.
21. Kuppermann M, Varner RE, Summitt RL Jr, Learman LA, Ireland C, Vittinghoff E, et al. Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. JAMA 2004;291:1447-55.
22. Barbosa I, Bakos O, Olsson SE, Odlind V, Johansson ED. Ovarian function during use of a levonorgestrel-releasing IUD. Contraception 1990;42:51-66.
23. Ronnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999;78:716-21.
24. Meirik O, Fraser IS, d'Arcangues C; WHO Consultation on Implantable Contraceptives for Women. Implantable contraceptives for women. Hum Reprod Update 2003;9:49-59.
25. Sivin I, Lahteenmaki P, Mishell DR Jr, Alvarez F, Diaz S, Ranta S, et al. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants. Contraception 1997;56:317-21.
26. McCoy NL, Davidson JM. A longitudinal study of the effects of menopause on sexuality. Maturitas 1985;7:203-10.
27. Wiklund I, Karlberg J, Lindgren R, Sandin K, Mattsson LA. A Swedish version of the women's health questionnaire. A measure of postmenopausal complaints. Acta Obstet Gynecol Scand 1993;72:648-55.
28. Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hysterectomy and sexual functioning. JAMA 1999;282:1934-41.
29. Butler-Manuel SA, Buttery LD, A'Hern RP, Polak JM, Barton DP. Pelvic nerve plexus trauma at radical and simple hysterectomy: a quantitative study of nerve types in the uterine supporting ligaments. J Soc Gynecol Investig 2002;9:47-56.
30. Butler-Manuel SA, Summerville K, Ford A, Blake P, Riley AJ, Sultan AH, et al. Self-assessment of morbidity following radical hysterectomy for cervical cancer. J Obstet Gynaecol 1999;19:180-3.
31. Baldaszti E, Wimmer-Puchinger B, Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception 2003;67:87-91.
32. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-44.
33. Avis NE, Zhao X, Johannes CB, Ory M, Brockwell S, Greendale GA. Correlates of sexual function among multi-ethnic middle-aged women: results from the study of women's health across the nation (SWAN). Menopause 2005;12:385-98.
34. Dennerstein L, Lehert P, Burger H, Dudley E. Factors affecting sexual functioning of women in the mid-life years. Climacteric 1999;2:254-62.
35. De Vogli R, Santinello M. Unemployment and smoking: does psychosocial stress matter? Tob Control 2005;14:389-95.
36. Cooper GS, Baird DD, Hulka BS, Weinberg CR, Savitz DA, Hughes CL Jr. Follicle-stimulating hormone concentrations in relation to active and passive smoking. Obstet Gynecol 1995;85:407-11.
37. Lambert-Messerlian GM, Harlow BL. The influence of depression, body mass index and smoking on serum inhibin B levels in late reproductive aged women. J Clin Endocrinol Metab 2006;91:1496-500.
38. Vestergaard P, Hermann AP, Stilgren L, Tofteng CL, Sorensen OH, Eiken P, et al. Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure-a randomised controlled study. Maturitas 2003;46:123-32.
39. Brunner RL, Gass M, Aragaki A, Hays J, Granek I, Woods N, et al. Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the women's health initiative randomized clinical trial. Arch Intern Med 2005;165:1976-86.